Characterizing the pharmacological interaction of the antimalarial combination artefenomel-piperaquine in healthy volunteers with induced blood-stage Plasmodium falciparum to predict efficacy in patients with malaria
Authors
Stephan Chalon (ORCID: https://orcid.org/0000-0002-9306-1851)
Characterizing the pharmacological interaction of the antimalarial combination artefenomel-piperaquine in healthy volunteers with induced blood-stage Plasmodium falciparum to predict efficacy in patients with malaria
Stephan Chalon, Stacey Llewellyn, Anne Kümmel, Adam J. Potter et al.
Citations
4 citations
Journal
BMC Medicine
Topics
Malaria Research and Control
Field-Weighted Citation Impact (FWCI)
2.17
article
Characterizing the pharmacological interaction of the antimalarial combination artefenomel-piperaquine in healthy volunteers with induced blood-stage Plasmodium falciparum to predict efficacy in patients with malaria
Stephan Chalon, Stacey Llewellyn, Anne Kümmel, Adam J. Potter, Louise Marquart, Lachlan Webb, Azrin N. Abd‐Rahman, Daniel Kaschek, Bridget E. Barber, James McCarthy, Myriam El Gaaloul, Anand Odedra, Stephen Woolley, Rebecca Webster, Jörg J. Möhrle
article en
4 citations
Abstract
No abstract available for this paper.
Publication Tag
BMC MedicineVol. 22(1)
Institutions
University College Hospital (GB), The Royal Melbourne Hospital (AU), Swiss Tropical and Public Health Institute (CH), The University of Queensland (AU), The University of Melbourne (AU), University of Basel (CH), Liverpool School of Tropical Medicine (GB), QIMR Berghofer Medical Research Institute (AU), Royal Brisbane and Women's Hospital (AU), Peter Doherty Institute (AU), University College London (GB), Medicines for Malaria Venture (CH)
Funders
Bill and Melinda Gates Foundation, QIMR Berghofer Medical Research Institute, Medicines for Malaria Venture, Medical Research Council, National Health and Medical Research Council